Non-small cell lung cancer (NSCLC) research hub

A Phase II, Multicenter, Open-Label Trial of DB-1311 in combination with BNT327 or DB-1305 in Participants with Advanced/Metastatic Solid Tumors

This study is testing new combinations of medicines (DB-1311 with BNT327 or DB-1305) for people with several types of advanced cancer. It aims to see how safe the treatments are and if they can shrink tumours, helping us find better ways to fight cancer.